The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches.
By J. Lieberman, D. Perkins, A. Belger, M. Chakos, F. Jarskog, K. Boteva, John H. Gilmore. Biological Psychiatry, 2001
603 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Clinical Psychology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/15fcda6c668a5ffde177de5eb16c5888bba85834
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Psychiatry and Mental health
Citations in the corpus
- Size of burden of schizophrenia and psychotic disorders. (2005, background): “Thus, ongoing psychosis could have direct ‘‘neurotoxic’’ effects, including neurodegeneration with symptomatic progression (Lieberman et al., 2001, Stahl, 2002) and cognitive deterioration (Amminger et al., 2002), although there are also studies that do not support this theory (e.g. Ho et al.,…”
- Remission in schizophrenia: proposed criteria and rationale for consensus. (2005, background): “symptomatic and functional status stabilizing thereafter (31).”